External broker reports(aggregated public sources), Axis Direct

Axis Direct

Axis Direct is the flagship brand under Axis Securities Limited, a subsidiary of Axis Bank in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only.  Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

External broker reports(aggregated public sources)

HCG: Firing On All Cylinders - All Set For FY24 To Be A Defining Year

HCG: Emerging Centers Are Inching Closer to Maturity

Axis Direct is the flagship brand under Axis Securities Limited, a subsidiary of Axis Bank in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Equity Bottom-Up

HealthCare Global Enterprises / Equity Bottom-Up

<ul><li>Healthcare Global Enterprises (HCG) reported revenue of Rs 420 Cr, up 19.2% YoY, and above our expectations.</li><li>The said growth was primarily driven by healthy ARPOB (Rs 37,000) which reported a growth of 1.5% YoY and the number of occupied bed days grew by 19.2% YoY.</li><li>The increase in ARPOB was led by high- end works such as robotic surgery and Cyberknife in Oncology verticals of Head &amp; Neck, Urology, Bone Marrow Transplantation, Liver Surgery, and complicated tumours.</li></ul><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

Healthcare Global Enterprises (HCG) reported revenue of Rs 420 Cr, up 19.2% YoY, and above our expectations.The said growth was primarily driven by healthy ARPOB (Rs 37,000) which reported a growth of 1.5% YoY and the number of occupied bed days grew by 19.2% YoY.The increase in ARPOB was led by high- end works such as robotic surgery and Cyberknife in Oncology verticals of Head &amp; Neck, Urology, Bone Marrow Transplantation, Liver Surgery, and complicated tumours.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Healthcare Global Enterprises Ltd - Outpacing the Industry Growth